Purpose The meta-analysis aims to investigate the relationship between anti-phospholipase
A2 receptor autoantibody (anti-PLA2R) and clinical characteristics and adverse outcomes of …

Background: Idiopathic membranous nephropathy (IMN) is the most common form of primary
nephrotic syndrome in adults. Antibodies against the M-type phospholipase A2 receptor …

Objective To investigate the correlation of M-type phospholipase A2 receptor (PLA2R)
expression and serum anti-PLA2R antibody with the clinical parameters and prognosis of …

Anti-PLA2R antibodies (Ab) are a diagnostic and prognostic biomarker in primary
membranous nephropathy (PMN). We assessed the relationship between the levels of anti …

Background Idiopathic membranous nephropathy (iMN) is recognized as an organ-specific
autoimmune disease, mainly caused by anti-PLA2R antibody. This study aimed to study …

Objectives: Autoantibodies against the M-type phospholipase A2 receptor 1 (anti-PLA2R1)
have been demonstrated to be very specific for idiopathic membranous nephropathy (MN) …

Background: M-type phospholipase A 2 receptor (PLA 2 R) has been identified as the major
target antigen in idiopathic membranous nephropathy (IMN). However, the role of …

Antibodies to the phospholipase A2 receptor 1 (PLA2R1) have been reported in 70% of
cases of idiopathic membranous nephropathy (IMN). The genetic susceptibility of IMN has …

Purpose We aimed to evaluate the prognostic value of serum anti-PLA2R and glomerular
PLA2R deposit (gPLA2R) in predicting remission of proteinuria in Primary Membranous …

Background: The presence of antibodies against phospholipase A2 receptor (PLA2R-Abs)
in serum at diagnosis is reported to be related to the rate of spontaneous remission in …